Page last updated: 2024-08-24

ibandronic acid and Hypercalcemia

ibandronic acid has been researched along with Hypercalcemia in 32 studies

Research

Studies (32)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's12 (37.50)18.2507
2000's19 (59.38)29.6817
2010's1 (3.13)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bachmann, R; Bisping, M; Born, AR; Cortesi, R; Glatt, M; Green, JR; Guiglia, G; Jaeggi, KA; Jeker, H; Klein, R; Müller, K; Ramseier, U; Schmid, J; Schreiber, G; Seltenmeyer, Y; Widler, L1
Ogrin, C1
Artunc, F; Friedrich, B; Georges, CG; Gröne, E; Guthoff, M; Müssig, K; Risler, T; Teichmann, R; Wehrmann, M1
Baraniskin, A; Schmiegel, W; Schroers, R1
Berenson, JR1
Bergström, B; Pecherstorfer, M; Rizzoli, R; Steinhauer, EU; Wetterwald, M1
Berenson, J; Hirschberg, R1
Diel, IJ; Pecherstorfer, M1
Heidenreich, A; Ohlmann, CH1
Bian, SG; Jiang, ZF; Li, LQ; Song, ST; Wang, T; Wang, YJ; Zhu, J1
Balla, J1
Lugassy, G1
Bergner, R; Bruckner, D; Henrich, DM; Hoffmann, M; Uppenkamp, M1
Guay, DR1
Daphnis, E; Karamitopoulou, E; Karkavitsas, N; Katsipi, I; Kyriazis, J; Stratigis, S; Stylianou, K1
Bergner, R; Henrich, D; Hoffmann, M; Uppenkamp, M1
Baumgartner, G; Blind, E; Pecherstorfer, M; Raue, F; Schilling, T; Ziegler, R; Zimmer-Roth, I1
Clemens, MR; Ghielmini, M; Jaeger, P; Krahl, D; Manegold, C; Scharla, SH; Schöter, KH; Thiébaud, D; Wüster, C1
Blind, E; Meinel, T; Raue, F; Wüster, C; Ziegler, R1
Body, JJ; Clemens, MR; Degardin, M; Herrmann, Z; Huss, HJ; Manegold, C; Pecherstorfer, M; Steinhauer, EU; Thiébaud, D; Thürlimann, B; Tubiana-Hulin, M; van Eijkeren, M1
Irzyniec, T; Kokot, F; Wiecek, A; Wnuk, RS1
Coleman, R; Vinholes, J1
Body, JJ; Dumon, JC; Oleffe, V1
Body, JJ; Hagberg, H; Herrmann, Z; Huss, HJ; Lichinitser, MR; Ralston, SH; Rizzoll, R; Steinhauer, EU; Thiébaud, D; Thürlimann, B; Tubiana-Hulin, M; Walls, J1
Burckhardt, P1
Bartl, R; Body, JJ; Burckhardt, P; Delmas, PD; Diel, IJ; Fleisch, H; Kanis, JA; Kyle, RA; Mundy, GR; Paterson, AH; Rubens, RD1
Balfour, JA; Dooley, M1
Body, JJ; Bundred, N; Clemens, MR; Degardin, M; Eghbali, H; Herrmann, Z; Huss, HJ; Manegold, C; Pecherstorfer, M; Rizzoli, R; Rückert, F; Steinhauer, EU; Thiébaud, D; Thürlimann, B; Tubiana-Hulin, M1
Body, JJ1
Alsina, M; Anderson, JL; Craig, F; Cruz, JC; Dallas, M; Roodman, GD; Yoneda, T1
Boewer, C; Delmas, PD; Euller-Ziegler, L; Facon, T; Fiere, D; Fontana, A; Herrmann, Z; Hrubisko, M; Lichinitser, MR; Menssen, HD; Sakalová, A; Singer, CR; Thiel, E; Wetterwald, M1

Reviews

11 review(s) available for ibandronic acid and Hypercalcemia

ArticleYear
[Emergencies in hematology and oncology].
    Deutsche medizinische Wochenschrift (1946), 2009, Volume: 134, Issue:38

    Topics: Acute Kidney Injury; Biopsy; Bone Density Conservation Agents; Carcinoma, Bronchogenic; Diphosphonates; Emergencies; Fatal Outcome; Fluid Therapy; Hemodiafiltration; Humans; Hypercalcemia; Ibandronic Acid; Lung; Lung Neoplasms; Male; Middle Aged; Palliative Care; Paraneoplastic Syndromes; Parathyroid Hormone; Parathyroid Hormone-Related Protein

2009
Treatment of hypercalcemia of malignancy with bisphosphonates.
    Seminars in oncology, 2002, Volume: 29, Issue:6 Suppl 21

    Topics: Bone Resorption; Clinical Trials as Topic; Clodronic Acid; Diphosphonates; Etidronic Acid; Humans; Hypercalcemia; Ibandronic Acid; Imidazoles; Neoplasms; Pamidronate; Zoledronic Acid

2002
Safety and convenience of a 15-minute infusion of zoledronic acid.
    The oncologist, 2004, Volume: 9, Issue:3

    Topics: Antineoplastic Agents; Bone Neoplasms; Clodronic Acid; Diphosphonates; Humans; Hypercalcemia; Ibandronic Acid; Imidazoles; Infusions, Intravenous; Pamidronate; Time Factors; Zoledronic Acid

2004
Rapid administration of ibandronate does not affect renal functioning: evidence from clinical studies in metastatic bone disease and hypercalcaemia of malignancy.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2004, Volume: 12, Issue:12

    Topics: Bone Neoplasms; Breast Neoplasms; Diphosphonates; Female; Humans; Hypercalcemia; Ibandronic Acid; Infusions, Intravenous; Injections, Intravenous; Kidney Diseases

2004
Ibandronate: its pharmacology and clinical efficacy in the management of tumor-induced hypercalcemia and metastatic bone disease.
    Expert review of anticancer therapy, 2004, Volume: 4, Issue:6

    Topics: Administration, Oral; Bone Density Conservation Agents; Bone Neoplasms; Bone Resorption; Diphosphonates; Humans; Hypercalcemia; Ibandronic Acid; Infusions, Intravenous; Neoplasms; Osteoporosis; Product Surveillance, Postmarketing; Risk Factors

2004
Ibandronate, an experimental intravenous bisphosphonate for osteoporosis, bone metastases, and hypercalcemia of malignancy.
    Pharmacotherapy, 2006, Volume: 26, Issue:5

    Topics: Bone Density Conservation Agents; Bone Neoplasms; Diphosphonates; Drug Interactions; Humans; Hypercalcemia; Ibandronic Acid; Injections, Intravenous; Neoplasms; Osteoporosis

2006
Tumor-induced hypercalcemia in a patient with extensive soft tissue sarcoma: effects of bisphosphonate therapy and surgery.
    Journal of surgical oncology, 1996, Volume: 63, Issue:2

    Topics: Adult; Bone Resorption; Chemotherapy, Adjuvant; Diphosphonates; Female; Humans; Hypercalcemia; Ibandronic Acid; Leg; Sarcoma, Synovial; Time Factors

1996
Ibandronate in oncology.
    Cancer, 1997, Oct-15, Volume: 80, Issue:8 Suppl

    Topics: Bone Density; Bone Neoplasms; Bone Resorption; Breast Neoplasms; Calcium; Diphosphonates; Female; Humans; Hypercalcemia; Ibandronic Acid; Neoplasms; Osteoporosis, Postmenopausal; Randomized Controlled Trials as Topic

1997
Current use of bisphosphonates in oncology. International Bone and Cancer Study Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1998, Volume: 16, Issue:12

    Topics: Analgesics, Non-Narcotic; Bone and Bones; Bone Neoplasms; Bone Resorption; Breast Neoplasms; Clodronic Acid; Diphosphonates; Humans; Hypercalcemia; Ibandronic Acid; Multiple Myeloma; Pain; Pamidronate

1998
Ibandronate.
    Drugs, 1999, Volume: 57, Issue:1

    Topics: Animals; Bone Density; Bone Neoplasms; Bone Resorption; Diphosphonates; Female; Humans; Hypercalcemia; Ibandronic Acid; Male; Neoplasms; Osteitis Deformans; Osteoporosis, Postmenopausal

1999
Current and future directions in medical therapy: hypercalcemia.
    Cancer, 2000, Jun-15, Volume: 88, Issue:12 Suppl

    Topics: Clodronic Acid; Diphosphonates; Humans; Hypercalcemia; Ibandronic Acid; Imidazoles; Neoplasms; Pamidronate; Zoledronic Acid

2000

Trials

7 trial(s) available for ibandronic acid and Hypercalcemia

ArticleYear
Efficacy and safety of ibandronate in the treatment of hypercalcemia of malignancy: a randomized multicentric comparison to pamidronate.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2003, Volume: 11, Issue:8

    Topics: Administration, Oral; Aged; Anti-Inflammatory Agents; Bone Resorption; Diphosphonates; Female; Humans; Hypercalcemia; Ibandronic Acid; Male; Middle Aged; Neoplasms; Pamidronate; Treatment Outcome

2003
[Clinical trial on ibandronate in patients with tumor-associated hypercalcemia].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2004, Volume: 26, Issue:12

    Topics: Bone Neoplasms; Breast Neoplasms; Calcium; Diphosphonates; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fever; Humans; Hypercalcemia; Ibandronic Acid; Lung Neoplasms; Male; Middle Aged; Multiple Myeloma; Phosphorus; Pruritus

2004
Methylpentylaminopropylidenebisphosphonate (BM 21.0955): a new potent and safe bisphosphonate for the treatment of cancer-associated hypercalcemia.
    Bone and mineral, 1993, Volume: 22, Issue:2

    Topics: Aged; Bone Resorption; Calcium; Diphosphonates; Female; Humans; Hypercalcemia; Ibandronic Acid; Injections, Intravenous; Male; Middle Aged; Neoplasms

1993
Randomized phase II trial comparing different doses of the bisphosphonate ibandronate in the treatment of hypercalcemia of malignancy.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1996, Volume: 14, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Bone Resorption; Calcium; Diphosphonates; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fever; Humans; Hypercalcemia; Ibandronic Acid; Male; Middle Aged; Nausea; Neoplasms; Recurrence; Regression Analysis; Thrombocytopenia; Treatment Outcome

1996
Dose-response study of ibandronate in the treatment of cancer-associated hypercalcaemia.
    British journal of cancer, 1997, Volume: 75, Issue:2

    Topics: Bone Resorption; Diphosphonates; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Hypercalcemia; Ibandronic Acid; Infusions, Intravenous; Male; Middle Aged

1997
Serum parathyroid hormone-related protein levels and response to bisphosphonate treatment in hypercalcemia of malignancy.
    The Journal of clinical endocrinology and metabolism, 1999, Volume: 84, Issue:10

    Topics: Absorption; Calcium; Cohort Studies; Diphosphonates; Female; Humans; Hypercalcemia; Ibandronic Acid; Kidney Tubules; Male; Middle Aged; Neoplasms; Parathyroid Hormone-Related Protein; Proteins; Recurrence; Syndrome; Treatment Outcome

1999
Effects of long-term intravenous ibandronate therapy on skeletal-related events, survival, and bone resorption markers in patients with advanced multiple myeloma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, May-01, Volume: 20, Issue:9

    Topics: Bone Resorption; Chi-Square Distribution; Diphosphonates; Double-Blind Method; Female; Fractures, Bone; Humans; Hypercalcemia; Ibandronic Acid; Injections, Intravenous; Male; Middle Aged; Multiple Myeloma; Pain; Spinal Cord Compression; Survival Analysis; Treatment Outcome

2002

Other Studies

14 other study(ies) available for ibandronic acid and Hypercalcemia

ArticleYear
Highly potent geminal bisphosphonates. From pamidronate disodium (Aredia) to zoledronic acid (Zometa).
    Journal of medicinal chemistry, 2002, Aug-15, Volume: 45, Issue:17

    Topics: Animals; Bone Resorption; Calcitriol; Diphosphonates; Hypercalcemia; Imidazoles; In Vitro Techniques; Kidney; Mice; Pamidronate; Parathyroidectomy; Rats; Skull; Structure-Activity Relationship; Thyroidectomy; Zoledronic Acid

2002
Evaluation of parathyroid levels and bone densitometry after cinacalcet treatment in severe primary hyperparathyroidism.
    Minerva endocrinologica, 2013, Volume: 38, Issue:3

    Topics: Alkaline Phosphatase; Bone Density; Calcium; Cinacalcet; Diphosphonates; Female; Follow-Up Studies; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Ibandronic Acid; Naphthalenes; Osteoporosis; Parathyroid Hormone; Phosphates; Vitamin D

2013
[Hypercalcaemic crisis and acute renal failure due to primary hyperparathyroidism].
    Deutsche medizinische Wochenschrift (1946), 2008, Volume: 133, Issue:Suppl 0

    Topics: Acute Kidney Injury; Adenoma; Diphosphonates; Emergencies; Female; Fluid Therapy; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Ibandronic Acid; Middle Aged; Parathyroid Neoplasms; Renal Dialysis

2008
[Bone metastases in breast carcinoma. Bisphosphonate protects from complications].
    MMW Fortschritte der Medizin, 2004, Apr-01, Volume: 146, Issue:14

    Topics: Administration, Oral; Bone Neoplasms; Bone Resorption; Breast Neoplasms; Clinical Trials as Topic; Diphosphonates; Female; Humans; Hypercalcemia; Ibandronic Acid; Time Factors

2004
The issue of renal safety of zoledronic acid from a nephrologist's point of view.
    The oncologist, 2005, Volume: 10, Issue:5

    Topics: Antineoplastic Agents; Bone Neoplasms; Clodronic Acid; Diphosphonates; Humans; Hypercalcemia; Ibandronic Acid; Imidazoles; Infusions, Intravenous; Pamidronate; Time Factors; Zoledronic Acid

2005
"Safety and convenience of a 15-minute infusion of zoledronic acid": not so safe.
    The oncologist, 2005, Volume: 10, Issue:5

    Topics: Antineoplastic Agents; Bone Neoplasms; Clodronic Acid; Diphosphonates; Humans; Hypercalcemia; Ibandronic Acid; Imidazoles; Infusions, Intravenous; Pamidronate; Time Factors; Zoledronic Acid

2005
[Therapy of hypercalcemia with ibandronate in case of acute renal failure].
    Der Internist, 2006, Volume: 47, Issue:3

    Topics: Acute Kidney Injury; Adenoma; Aged; Bone Density Conservation Agents; Calcium; Creatinine; Diagnosis, Differential; Diphosphonates; Female; Humans; Hypercalcemia; Hyperparathyroidism; Ibandronic Acid; Parathyroid Hormone; Parathyroid Neoplasms; Parathyroidectomy; Recurrence

2006
Parathyromatosis and the challenge of treatment.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2006, Volume: 48, Issue:3

    Topics: Adult; Bone Density Conservation Agents; Diphosphonates; Disease Progression; Ergocalciferols; Female; Humans; Hypercalcemia; Hyperparathyroidism; Ibandronic Acid; Kidney Failure, Chronic; Renal Dialysis; Reoperation

2006
Ibandronate for the treatment of hypercalcemia or nephrocalcinosis in patients with multiple myeloma and acute renal failure: Case reports.
    Acta haematologica, 2006, Volume: 116, Issue:3

    Topics: Acute Kidney Injury; Aged; Calcium; Creatinine; Diphosphonates; Fatal Outcome; Female; Humans; Hypercalcemia; Ibandronic Acid; Injections, Intravenous; Male; Middle Aged; Multiple Myeloma; Nephrocalcinosis

2006
Parathyroid hormone-related protein and life expectancy in hypercalcemic cancer patients.
    The Journal of clinical endocrinology and metabolism, 1994, Volume: 78, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Diphosphonates; Female; Humans; Hypercalcemia; Ibandronic Acid; Life Expectancy; Male; Middle Aged; Neoplasms; Pamidronate; Parathyroid Hormone-Related Protein; Proteins; Survival Rate

1994
Levels of parathyroid hormone-related protein (PTHrP) in hypercalcemia of malignancy are not lowered by treatment with the bisphosphonate BM 21.0955.
    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1993, Volume: 25, Issue:1

    Topics: Adult; Aged; Calcium; Diphosphonates; Female; Humans; Hypercalcemia; Ibandronic Acid; Male; Middle Aged; Neoplasms; Parathyroid Hormone-Related Protein; Proteins

1993
[Use of third generation bisphosphonates in treatment of neoplastic hypercalcemia].
    Polski tygodnik lekarski (Warsaw, Poland : 1960), 1995, Volume: 50, Issue:44-47

    Topics: Adult; Aged; Calcium; Creatinine; Diphosphonates; Female; Humans; Hypercalcemia; Ibandronic Acid; Male; Middle Aged; Neoplasms

1995
The management of bone metastases.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1995, Volume: 6, Issue:7

    Topics: Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Combined Modality Therapy; Diphosphonates; Female; Humans; Hypercalcemia; Ibandronic Acid; Middle Aged; Pain

1995
Ibandronate decreases bone disease development and osteoclast stimulatory activity in an in vivo model of human myeloma.
    Experimental hematology, 2001, Volume: 29, Issue:4

    Topics: Animals; Bone Diseases; Bone Marrow Cells; Cell Division; Cell Survival; Diphosphonates; Disease Models, Animal; Humans; Hypercalcemia; Ibandronic Acid; Immunoglobulin G; Immunoglobulin kappa-Chains; Leukemia, Plasma Cell; Mice; Mice, SCID; Multiple Myeloma; Neoplasm Transplantation; Osteoclasts; Osteolysis; Paraplegia; Tumor Cells, Cultured

2001